← All trials
NCT07226219
Phase 1Interventional
Includes initial studies to determine the metabolism and pharmacologic actions of drugs in humans, the side effects associated with increasing doses, and to gain early evidence of effectiveness; may include healthy participants and/or patients.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Nov 25, 2025
- Primary completion
- Jul 31, 2027
- Completion date
- Aug 31, 2028
- First posted
- Nov 10, 2025
- Last posted
- Nov 28, 2025
- Enrollment
- 72
- Arms / groups
- 1 / —
- Source
- AACT · ctgov ingestion
Sponsors
- St. Jude Children's HospitalLead sponsor
- St. Jude Children's HospitalOfficial
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.